Your AI-Trained Oncology Knowledge Connection!

Kathleen I. Pritchard, MD, FRCPC

home / authors / kathleen-i-pritchard-md-frcpc

Articles

Bone-Targeted Therapy in Early Breast Cancer

Katarzyna J. Jerzak, MD, MSc, FRCPC;Jacques Raphael, MD, MSc, FRCPC;Danielle N. Desautels, MD, MSc, FRCPC;Phillip S. Blanchette, MD, MSc, FRCPC;Ivan Tyono, BScPhm, RPh;Kathleen I. Pritchard, MD, FRCPC

November 15th 2018

In this article, we describe the role of bone-targeted therapies, specifically for managing early breast cancer, by reviewing their bone-specific and cancer-specific benefits.

The Role of Bisphosphonates in Early- and Advanced-Stage Breast Cancer: Have We Finally Optimized Care?

Phillip S. Blanchette, MD, MSc, FRCPC;Kathleen I. Pritchard, MD, FRCPC

January 15th 2015

Bisphosphonates have played an important role in the treatment of breast cancer, mainly in patients with bone metastasis, by reducing the risk of fracture, spinal cord compression, and hypercalcemia.